SEC Form 4 · accession 0001104659-17-019771
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President and General Counsel · Director
Period of report
Mar 26, 2017
Accepted (ET)
Mar 28, 2017 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 26, 2017 | F | 4,714 | $13.76 | D | 255,108 | D | |
| Common StockF1 | Mar 27, 2017 | F | 5,938 | $14.27 | D | 249,170 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.